MEG ZERINGUE: Open Payments
NPI 1336444546 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 79 payments from 24 companies in 2025. Trend: 2023 $1,628 · 2024 $1,603 · 2025 $1,829
Food & beverage: $1,735Education: $94
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $238 |
| PFIZER INC. | 10 | $205 |
| Janssen Biotech, Inc. | 5 | $173 |
| AstraZeneca Pharmaceuticals LP | 5 | $131 |
| Astellas Pharma US Inc | 4 | $110 |
| Gilead Sciences, Inc. | 4 | $104 |
| Lilly USA, LLC | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $78 |
| Stemline Therapeutics Inc. | 3 | $75 |
| BeOne Medicines USA, Inc. | 3 | $67 |
Products named: KEYTRUDA, PADCEV, DARZALEX, Trodelvy, BRUKINSA, XTANDI, ZYNLONTA, RYBREVANT.
Industry payments across GA — which companies pay providers there.
